NEFL and myeloid sarcoma: Several recent studies have indicated the prognostic and predictive value of measuring concentrations of NfL in the peripheral blood in chronic neurological diseases including amyotrophic lateral sclerosis (ALS)38, multiple sclerosis (MS)39, AD40, Parkinson’s Disease (PD)13, as well as peripheral neuropathies41.